Get the Stockscreener App
29.21
4.40%
1.23
After Hours:
30.99
1.78
+6.09%
Azenta Inc stock is traded at $29.21, with a volume of 547.11K.
It is up +4.40% in the last 24 hours and down -12.73% over the past month.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
See More
Previous Close:
$27.98
Open:
$28.21
24h Volume:
547.11K
Relative Volume:
0.63
Market Cap:
$1.34B
Revenue:
$656.32M
Net Income/Loss:
$-164.17M
P/E Ratio:
-9.804
EPS:
-2.9794
Net Cash Flow:
$12.90M
1W Performance:
+8.59%
1M Performance:
-12.73%
6M Performance:
-35.55%
1Y Performance:
-46.31%
1-Day Range:
$28.01
$29.30
1-Week Range:
$27.60
$29.84
52-Week Range:
$23.91
$55.63
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
29.21 | 1.28B | 656.32M | -164.17M | 12.90M | -2.9794 |
|
ISRG
Intuitive Surgical Inc
|
478.19 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
194.96 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.03 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
283.29 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
239.90 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Azenta EVP Lin buys $69,900 in shares By Investing.com - Investing.com Australia
Azenta EVP Lin buys $69,900 in shares - Investing.com
Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know - TradingView
How to forecast Azenta Inc. trends using time seriesStock Entry Point Planner with Volume Spike - Newser
Smart tools for monitoring Azenta Inc.’s price actionFree Earnings Play Trade Plan With Alerts - Newser
Has Azenta Inc. formed a bullish divergenceMulti-Year Investment Performance Summary Report - Newser
Volume spikes in Azenta Inc. stock – what they meanTechnical Entry Plan with Risk Minimization - Newser
New Product Launches: Will They Boost Azenta Inc. Stock in 2025Bear Market Safe Zone Technical Analysis - Newser
Azenta upgraded to Outperform from Market Perform at Raymond James - MSN
What makes Azenta Inc. stock price move sharplyHigh Return in Low Timeframe - thegnnews.com
Visual analytics tools that track Azenta Inc. performanceRisk Aware Trading Ideas with Alert Levels - Newser
Should I trade or invest in Azenta Inc.Big Money Stock Playbook - mustnews.co.kr
Raymond James Financial Upgrades Azenta (NASDAQ:AZTA) to “Outperform” - Defense World
Evercore ISI Reiterates “$33.00” Price Target for Azenta (NASDAQ:AZTA) - Defense World
Why Azenta (AZTA) Stock Is Up Today - TradingView
Azenta 2025 Q3 Earnings Deepening Losses Amid Flat Revenue - AInvest
Azenta, Inc. (NASDAQ:AZTA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Evercore ISI Has Lowered Expectations for Azenta (NASDAQ:AZTA) Stock Price - Defense World
Azenta (NASDAQ:AZTA) Trading 8.8% Higher on Strong Earnings - Defense World
Azenta Inc Q3 2025 Earnings Call Highlights: Robust Financial Position Amid Revenue Challenges - AInvest
Azenta, Inc. Earnings Call: Balancing Growth and Challenges - The Globe and Mail
Optimistic Buy Rating for Azenta: Margin Improvements and Market Potential Highlighted - TipRanks
Azenta reaffirms 3%–5% organic growth and 300bps margin expansion for 2025 as operational turnaround advances - MSN
Azenta, Inc. SEC 10-Q Report - TradingView
Azenta (AZTA) Stock Trades Up, Here Is Why - TradingView
Azenta, Inc. (NASDAQ:AZTA) Q3 2025 Earnings Call Transcript - Insider Monkey
Raymond James Upgrades Azenta to Outperform From Market Perform - MarketScreener
Azenta's Q3 2025 Earnings Call: Unpacking Contradictions in NIH Funding, Growth Projections, and Market Dynamics - AInvest
Azenta stock upgraded to Outperform by Raymond James on margin improvement - Investing.com
Azenta Inc (AZTA) Q3 2025 Earnings Call Highlights: Strong Financial Position Amid Revenue ... By GuruFocus - Investing.com Canada
Azenta (NASDAQ:AZTA) Shares Gap Down After Analyst Downgrade - Defense World
Azenta, Inc. Reports Steady Q3 2025 Earnings - TipRanks
Can Azenta Inc. recover in the next quarterFree High Yield Stock Screening Results - Newser
Azenta's Q3 2025 Earnings Call: Dissecting Contradictions in Revenue Growth, Leadership Changes, and NGS Momentum - AInvest
Azenta's Q3 2025 Earnings and Strategic Position in the Gene Therapy Market: A Deep Dive into Growth Catalysts and Financial Resilience - AInvest
Azenta, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:AZTA) - Seeking Alpha
Why Azenta (AZTA) Stock Is Trading Lower Today - TradingView
Earnings call transcript: Azenta’s Q3 2025 earnings beat EPS expectations - Investing.com
Evercore ISI lowers Azenta stock price target to $33 on order delays - Investing.com
Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets - TradingView
Azenta earnings beat by $0.06, revenue fell short of estimates - Investing.com UK
Earnings Flash (AZTA) Azenta, Inc. Reports Q3 Revenue $143.9M, vs. FactSet Est of $149.4M - MarketScreener
Earnings Flash (AZTA) Azenta, Inc. Posts Q3 Adjusted EPS $0.19 per Share - MarketScreener
Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance - PR Newswire
Cwm LLC Sells 1,028 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Using flow based indicators on Azenta Inc.Swing Trade Planning with Consistent Setup - Newser
Azenta to Release Q3 2025 Earnings on August 5, 2025, and Host Conference Call and Webcast. - AInvest
Chart overlay techniques for tracking Azenta Inc.Real Trader Watchlist with Entry Targets - Newser
Azenta Inc. Inches Above Key Support — Safe to HoldEntry Plan for Oversold Reversal Stocks Released - beatles.ru
What the charts say about Azenta Inc. todayPredictable Return Strategy with AI Support - Newser
Short interest data insights for Azenta Inc.Daily Swing Candidate Analysis with Chart Patterns - Newser
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Azenta Inc Stock (AZTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Zhou Ginger | SVP and General Manager, Genom |
Jan 31 '25 |
Buy |
45.88 |
417 |
19,132 |
27,916 |
| Pirogova Olga | SVP and CHRO |
Nov 19 '24 |
Sale |
40.07 |
548 |
21,958 |
19,373 |
| Hughes Violetta | VP, Chief Accounting Officer |
Nov 19 '24 |
Sale |
40.07 |
163 |
6,531 |
9,920 |
| Zhou Ginger | SVP and General Manager, Genom |
Nov 19 '24 |
Sale |
40.07 |
491 |
19,674 |
27,499 |
| Wang David Dong | SVP & GM, SMS |
Nov 19 '24 |
Sale |
40.07 |
348 |
13,944 |
24,114 |
| Joseph Jason | SVP, General Counsel, Secy. |
Nov 19 '24 |
Sale |
40.07 |
1,139 |
45,640 |
112,564 |
| Cueto Herman | EVP, Chief Financial Officer |
Nov 19 '24 |
Sale |
40.07 |
712 |
28,530 |
23,892 |
| Marotta John | President and CEO |
Nov 18 '24 |
Buy |
39.48 |
12,717 |
502,066 |
99,612 |
| Marotta John | President and CEO |
Nov 19 '24 |
Buy |
40.67 |
1,250 |
50,838 |
100,862 |
| Cornog William L | Director |
Nov 18 '24 |
Buy |
39.60 |
12,500 |
495,000 |
14,755 |
4.21%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):